For all those who are not subscribed to the Replicel updates, here is a new interview with David Hall:
Nothing new but will be of interest to many.
It sounds like Replicel have paid ViralNetwork Inc to ask David questions they provided. They may have even scripted every word.
Replicel are pushing so hard at this point, why don't they focus on their trials? Are they really that separate for funding? Surely they can get a big investor and forget the small stocks?
Nothing new but will be of interest to many.
It sounds like Replicel have paid ViralNetwork Inc to ask David questions they provided. They may have even scripted every word.
Replicel are pushing so hard at this point, why don't they focus on their trials? Are they really that separate for funding? Surely they can get a big investor and forget the small stocks?
Comment